Yerem Yeghiazarians

By James Waldron SOUTH SAN FRANCISCO — Soley Therapeutics secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its lead acute myeloid leukemia[...]

SAN FRANCISCO — In a San Francisco lab, Dr. Yerem Yeghiazarians hopes to treat heart disease, stroke and a whole host of other serious illnesses with the pioneering use of[...]